Google News
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) MerckMerck, girding for Keytruda cliff...
Source: Google News
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) MerckMerck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition Fierce BiotechMerck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline CNBCMerck To Buy Terns, ‘Unprecedented’ Leukemia Drug for $6.7B as Keytruda Cliff Looms BioSpaceMerck seals $5.7bn biotech deal to boost cancer drug pipeline Financial Times